State of Wyoming’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$417K Buy
+2,208
New +$386K 0.05% 445
2025
Q4
Sell
-3,664
Closed -$483K 1960
2025
Q3
$483K Sell
3,664
-365
-9% -$43.8K 0.06% 338
2025
Q2
$428K Buy
4,029
+709
+21% +$77K 0.05% 382
2025
Q1
$412K Sell
3,320
-1,111
-25% -$145K 0.05% 339
2024
Q4
$546K Buy
4,431
+2,251
+103% +$265K 0.07% 221
2024
Q3
$243K Sell
2,180
-79
-3% -$8.66K 0.03% 577
2024
Q2
$241K Buy
2,259
+173
+8% +$19K 0.04% 440
2024
Q1
$251K Buy
2,086
+135
+7% +$16.5K 0.04% 448
2023
Q4
$240K Buy
1,951
+315
+19% +$39.3K 0.04% 439
2023
Q3
$212K Sell
1,636
-251
-13% -$33.4K 0.05% 415
2023
Q2
$234K Buy
1,887
+247
+15% +$33.2K 0.07% 286
2023
Q1
$240K Buy
1,640
+96
+6% +$14.2K 0.08% 235
2022
Q4
$246K Buy
1,544
+540
+54% +$79.1K 0.08% 211
2022
Q3
$133K Buy
1,004
+860
+597% +$131K 0.07% 430
2022
Q2
$22K Buy
144
+106
+279% +$16.3K 0.01% 1388
2022
Q1
$6K Sell
38
-171
-82% -$24.8K ﹤0.01% 1647
2021
Q4
$27K Buy
209
+41
+24% +$5.39K 0.01% 1388
2021
Q3
$22K Sell
168
-441
-72% -$66.6K 0.01% 922
2021
Q2
$108K Buy
+609
New +$105K 0.07% 416

Other funds holding JAZZ

State of Wyoming's JAZZ Position: Q1 2026 in Review

State of Wyoming opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 2,208 shares worth $417K. The stake represents 0.05% of the portfolio and ranks #445 among its holdings. This is a return to the name: State of Wyoming previously reported a position in JAZZ as recently as Q3 2025.

State of Wyoming first reported a position in JAZZ in Q2 2021 and has held it in 19 quarters since. The position peaked at $546K in Q4 2024. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • State of Wyoming held 2,208 shares of Jazz Pharmaceuticals worth $417K as of Q1 2026.
  • Jazz Pharmaceuticals was a new State of Wyoming position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.05% of State of Wyoming's portfolio in Q1 2026, its #445 holding.
  • State of Wyoming first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • State of Wyoming's Jazz Pharmaceuticals position peaked at $546K in Q4 2024.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.